Ingemar Persson
Impact in
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments
Papers in
- Genetics 35
- Estrogen and related hormone effects 31
-
- MXene and MAX Phase Materials 16
- 2D Materials and Applications 12
- Graphene research and applications 8
- Co-authors
- Hans‐Olov Adami (30 shared papers)Leif Bergkvist (12 shared papers)Catherine Schairer (7 shared papers)John A. Baron (13 shared papers)Per O. Å. Persson (21 shared papers)Johanna Rosén (14 shared papers)Justinas Pališaitis (12 shared papers)Cecilia Magnusson (16 shared papers)
- Journals
- International Journal of Cancer (15 papers)Acta Obstetricia Et Gynecologica Scandinavica (9 papers)Cancer Causes & Control (6 papers)Nanoscale (4 papers)Pharmacoepidemiology and Drug Safety (4 papers)
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Ingemar Persson
120 papers receiving 10.1k citations
Ingemar Persson's Hit Papers
Peers
Comparison fields: 5 of 159
- Reproductive Medicine 1.3k
- Obstetrics and Gynecology 745
- Endocrinology, Diabetes and Metabolism 1.5k
- Oncology 2.0k
- Genetics 2.1k
Countries citing papers authored by Ingemar Persson
This map shows the geographic impact of Ingemar Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingemar Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingemar Persson more than expected).
Fields of papers citing papers by Ingemar Persson
This network shows the impact of papers produced by Ingemar Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingemar Persson. The network helps show where Ingemar Persson may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingemar Persson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months Hit paper breakdown → | 2006 | 1527 |
| 2 | 1989 | 498 | |
| 3 | 1997 | 452 | |
| 4 | 1986 | 451 | |
| 5 | 1999 | 342 | |
| 6 | 2017 | 300 | |
| 7 | 1996 | 279 | |
| 8 | Boridene: Two-dimensional Mo 4/3 B 2-x with ordered metal vacancies obtained by chemical exfoliation Hit paper breakdown → | 2021 | 272 |
| 9 | 1992 | 271 | |
| 10 | 2018 | 246 | |
| 11 | 2018 | 245 | |
| 12 | 1999 | 234 | |
| 13 | 1989 | 230 | |
| 14 | 2000 | 217 | |
| 15 | 1998 | 194 | |
| 16 | 2000 | 192 | |
| 17 | 1999 | 175 | |
| 18 | 2004 | 171 | |
| 19 | 2020 | 170 | |
| 20 | 1998 | 169 |
About Ingemar Persson
Ingemar Persson is a scholar working on Genetics, Materials Chemistry, Oncology, Reproductive Medicine and Endocrinology, Diabetes and Metabolism, having authored 123 papers that have together received 10.6k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (31 papers), Cancer Risks and Factors (27 papers), Ovarian cancer diagnosis and treatment (16 papers), MXene and MAX Phase Materials (16 papers), Menopause: Health Impacts and Treatments (14 papers), 2D Materials and Applications (12 papers), Endometrial and Cervical Cancer Treatments (10 papers) and Graphene research and applications (8 papers). The work is most often cited by research in Reproductive Medicine (1.3k citations), Obstetrics and Gynecology (745 citations), Endocrinology, Diabetes and Metabolism (1.5k citations), Oncology (2.0k citations) and Genetics (2.1k citations). Ingemar Persson has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Hans‐Olov Adami, Leif Bergkvist, Catherine Schairer, John A. Baron, Per O. Å. Persson, Johanna Rosén, Justinas Pališaitis, Cecilia Magnusson, Joseph Halim and Robert N. Hoover. Their work appears in journals such as International Journal of Cancer, Acta Obstetricia Et Gynecologica Scandinavica, Cancer Causes & Control, Nanoscale and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.